Desk›Healthcare› Biocon Ltd
Biocon Ltd
BSE 532523 · NSE BIOCON · ISIN INE376G01013 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹417.80
+0.10%
BSE close, 28 August 2026
₹68,088.62 cr
163.0 cr shares · Mid cap
₹29,021.07 cr
as published
696.3× · 6.25×
EPS ₹0.60 · BV ₹66.85
2,346.40 / 37.20
₹ cr, as filed
35
13 selected · 37%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -6.5% |
|---|---|
| Against 52-week low | +23.9% |
| Day change | +0.10% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹0.60 |
|---|---|
| Price / earnings | 696.33× |
| Price / book | 6.25× |
| Book value — derived, price ÷ P/B | ₹66.85 |
| Return on equity | 0.90% |
| Operating margin | 20.11% |
| Net margin | 8.36% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 0.90%
- ROE as published
- 0.90%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 624.50 | 52.20 | 0.32 | 20.11% | 8.36% |
| Mar-26 · Q | 604.70 | 51.00 | 0.32 | 18.24% | 8.43% |
| FY25-26 | 2,346.40 | 37.20 | 0.27 | 14.09% | 1.59% |
Quarter on quarter
- Revenue, quarter on quarter
- +3.3%
- Net profit, quarter on quarter
- +2.4%
- Operating margin, quarter on quarter
- +187 bps
Disclosure profile 35 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Directorate | 4 |
| Press Release | 4 |
| Auditor Resignation | 1 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 13 |
| Procedural | |
| General | 9 |
| Analyst / Investor Meet | 6 |
| AGM / EGM | 1 |
| Auditor Appointment | 1 |
| Board Meeting | 1 |
| Monitoring Agency | 1 |
| Newspaper Publication | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 22 |
| Total | 35 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
35 filings · 13 selected · busiest 2026-08-06
Filing rhythm · the twelve most recent
2026-08-182026-10-01
SelectedProcedural
Filings
35 in the window · 17 earlier on record
-
1 October 2026 ·
Grant Of Employee Stock Options Under Biocon Unity Long Term Inc entive Plan 2026 Read With The Notified Plans Thereunder
Grant of Employee Stock Options
Company Update / General View filing →
-
30 September 2026 ·
Closure of Trading Window
Intimation regarding closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 September 2026 ·
-
21 September 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
9 September 2026 ·
Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Communication regarding remittance of final dividend for the FY 2025-26
Company Update / General View filing →
-
8 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
Company Update / Analyst / Investor Meet View filing →
-
8 September 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
31 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
Company Update / Analyst / Investor Meet View filing →
-
28 August 2026 ·
Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Communication regarding remittance of final dividend for the FY 2025-26
Company Update / General View filing →
-
26 August 2026 ·
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mylan Inc.
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 August 2026 ·
-
18 August 2026 ·
-
11 August 2026 ·
Analyst / Investor Meet - Intimation
Investor Meet
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026 ·
Earnings Call Transcript
Earning call Transcript for Q1 FY27
Company Update / Earnings Call Transcript View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Intimation
Investor Meet
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
-
6 August 2026 ·
Resignation of Statutory Auditors
Resignation of Statutory auditors of material subsidiaries of the Company.
Company Update / Resignation of Statutory Auditors View filing →
-
6 August 2026 ·
-
6 August 2026 ·
Completion Of Tenure Of Statutory Auditors
Completion of tenure of Statutory Auditors
Company Update / General View filing →
-
6 August 2026 ·
Appointment of Statutory Auditor/s
Appointment of Statutory Auditors
Company Update / Appointment of Statutory Auditor/s View filing →
-
6 August 2026 ·
-
6 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 48th AGM of the Company and the Chairperson's speech.
AGM/EGM / AGM View filing →
-
6 August 2026 ·
Analyst / Investor Meet - Outcome
Audio and video recording of Q1 2027
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026 ·
-
5 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report
Company Update / Monitoring Agency Report View filing →
-
5 August 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
5 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Outcome Of Board Meeting-Financial Results
Outcome of Board Meeting- Financial Results
Result / Financial Results View filing →
-
3 August 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
3 August 2026 ·
-
29 July 2026 ·
-
28 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Earnings Conference call for Analysts and Investors
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026 ·
Board Meeting Intimation for Intimation For The Board Meeting And Earnings Conference Call For Analysts And Investors
Biocon Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Intimation for the Board Meeting and ....
Board Meeting / Board Meeting View filing →
-
22 July 2026 ·
Change in Directorate
Completion of tenure of Independent Director
Company Update / Change in Directorate View filing →
-
22 July 2026 ·
Change in Directorate
Completion of tenure of Independent Director
Company Update / Change in Directorate View filing →
RSS feed for Biocon Ltd · the 50 most recent filings